Genzyme To Cough Up $64M To Settle Suit
Biotechnology company Genzyme Corp. will pay $64 million to settle a four-year-long squabble with shareholders over changes to the company's stock structure....To view the full article, register now.
Already a subscriber? Click here to view full article